25.80
Regencell Bioscience Holdings Ltd stock is traded at $25.80, with a volume of 140.15K.
It is down -4.44% in the last 24 hours and down -11.92% over the past month.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
See More
Previous Close:
$27.00
Open:
$27.01
24h Volume:
140.15K
Relative Volume:
1.08
Market Cap:
$12.76B
Revenue:
-
Net Income/Loss:
$-7.05M
P/E Ratio:
-1,816.90
EPS:
-0.0142
Net Cash Flow:
$-767.30K
1W Performance:
-9.73%
1M Performance:
-11.92%
6M Performance:
+106.73%
1Y Performance:
-94.16%
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Compare RGC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
RGC
Regencell Bioscience Holdings Ltd
|
25.80 | 13.35B | 0 | -7.05M | -767.30K | -0.0142 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Regencell Bioscience Holdings Ltd Stock (RGC) Latest News
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Regencell Bioscience Holdings (RGC) Stock Analysis: Is This Hong Kong Healthcare Player Set for a Breakthrough? - DirectorsTalk Interviews
ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC - GlobeNewswire Inc.
Regencell (RGC) raises $20M in registered direct stock offering - Stock Titan
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell - GlobeNewswire
A Look At Regencell Bioscience Holdings (RGC) Valuation After Lawsuits And DOJ Trading Investigation - simplywall.st
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Regencell Bioscience (NASDAQ: RGC) sells 985,222 shares at $20.30 - Stock Titan
Regencell Bioscience announces $20 million direct offering of ordinary shares - Investing.com
Regencell Bioscience (RGC) to raise about $20M in registered direct share sale - Stock Titan
Regencell (Nasdaq: RGC) prices $20M registered direct offering - Stock Titan
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Barchart.com
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit - Barchart
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
How Investors May Respond To Regencell Bioscience Holdings (RGC) Widening Half-Year Net Loss And Per-Share Deficit - simplywall.st
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - PR Newswire
VinFast, Alcoa, and Regencell are among the top 10 large-cap gainers last week (March 30-April 2): Are the others in your portfolio? - MSN
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain OfficersRGC - PR Newswire
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
TradingKey - TradingKey
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
RGC Deadline Alert: The Gross Law Firm Reminds Regencell Bioscience Holdings Limited (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - Barchart.com
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class ActionRGC - TMX Newsfile
Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a $14.48 Billion Market Cap Amidst Undefined Financial Metrics - DirectorsTalk Interviews
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Probe And Class Action Lawsuits - Sahm
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC - Scott Coop
Best Chinese Stocks To Follow TodayMay 9th - MarketBeat
[6-K] Regencell Bioscience Holdings Ltd Current Report (Foreign Issuer) | RGC SEC FilingForm 6-K - Stock Titan
Regencell Bioscience (NASDAQ:RGC) Trading Down 9%What's Next? - MarketBeat
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGC Shareholder Alert: Regencell Bioscience Holdings - GlobeNewswire
Regencell Bioscience (NASDAQ:RGC) Trading 11.1% HigherTime to Buy? - MarketBeat
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Regencell - GlobeNewswire
RGC DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - PR Newswire
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Chinese Stocks To Add to Your WatchlistMay 6th - MarketBeat
Robbins LLP Urges RGC Investors Who Lost Money Investing in Regencell Bioscience Holdings Limited to Contact the Firm for Information About Leading the Securities Class Action - Barchart.com
Lawsuit Alert: Investors who lost money with Regencell - openPR.com
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Regencell Bioscience Holdings (RGC) Is Down 6.3% After DOJ Probe Spurs Class Actions Over Valuation Narrative - Sahm
Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP - Scott Coop
2026-05-04 | RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:RGC | Press Release - Stockhouse
Regencell Bioscience Holdings L (RGC): Growth Potential In The Booming TCM Market - DirectorsTalk Interviews
Regencell Bioscience Holdings Ltd Stock (RGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):